Learning Objectives

1. MEDICO-LEGAL

  • Cannabis History, Policy, and Law
    • Identify the key historical events associated with the medicinal use of Cannabis
    • Understand the process involved with medical Cannabis research
    • Contrast the rules, the regulations, and the federal issues of medicinal Cannabis in medical-legal states
    • Describe the roles of Medical Providers in different medical-legal states
  • Public Health – Risks and Potential Benefits
    • Identify the potential benefits – and risks – of cannabis-based medicine in adult and pediatric patients.
    • Describe four elements of patient and family education regarding cannabis.
    • Describe barriers for elderly patients to access cannabis-based medicine
    • Describe the role of caregivers for pediatric, disabled, and elderly patients receiving cannabis-based medicine

 

2. BIOLOGY AND BASIC SCIENCE

  • The Endocannabinoid System
    • Describe at least 3 unique characteristics of the endocannabinoid system
    • Explain implications of the endocannabinoid system on the use of cannabis as medication
    • Discuss the concept of endocannabinoid deficiency syndrome
  • The Phytocannabinoids and Terpenes
    • Identify phytocannabinoids, and contrast Marinol with cannabis occurring in nature
    • Understand the differences between phytocannabinoids
    • Describe terpenes and the entourage effect

 

3. CLINICAL PRACTICE 1 – PHYSIOLOGY AND PHARMACOLOGY

  • Physiological and Adverse Effects
    • Describe the pharmacology and toxicology of Cannabis and Cannabis-based products
    • Identify side effects associated with the acute and chronic use of medicinal cannabis
    • Describe cannabis’ effects on brain function in adolescents
    • Outline risk factors associated with the initiation or maintenance of cannabinoid therapies for pain, and strategies for referral when substance abuse is present
    • Explain risks to patients
  • Preparations and Dosage
    • Identify the cannabis-based pharmaceuticals currently available in the US market and abroad
    • Discuss four common routes of administration of cannabis
    • Discuss dosing and pharmacokinetics of medical marijuana
    • Explain to patients the pharmacology of cannabinoids and terpenes and the best indications for clinical use

 

4. CLINICAL PRACTICE 2 –PAIN SYNDROMES

  • Clinical Practice – Chronic Pain
    • Critically review and assess the current evidence for safety and efficacy of Cannabis and Cannabis-based products for chronic pain
    • Discuss decision-making strategies including non-cannabinoid and non-pharmacologic strategies for the management of pain
    • Determine which patients may benefit from using medicinal cannabis for chronic pain
    • Describe how to titrate medicinal cannabis to best manage chronic pain and ween patients from opioids
  • Clinical Practice – Cancer and Palliative Care
    • Critically review and assess the current evidence for safety and efficacy of cannabis products for cancer and palliative care
    • Assess when cannabis may be an appropriate treatment option for oncology patients, including specialties such as pediatric oncology
    • Identify the risks associated with the use of smoked cannabis in immunocompromised patients
    • Employ strategies that integrate care across disciplines
    • Create individualized care for special populations including patients requiring palliative care

 

5. CLINICAL PRACTICE 3 – MOTOR DISORDERS

  • Clinical Practice – MS and Parkinson’s Disease
    • Critically review and assess the current evidence for safety and efficacy of cannabis for MS and Parkinson’s disease
    • Explain the recent neuropharmacology of THC and the other cannabinoids
    • Apply evidence-based strategies for managing the patient with motor disorders, including formulation of the treatment plan when cannabinoids are used
    • Employ strategies that integrate care across disciplines
  • Clinical Practice – Seizures
    • Critically review and assess the current evidence for safety and efficacy of cannabis for seizures
    • Explain the recent research supporting the efficacy CBD for pediatric seizure conditions
    • Apply evidence-based strategies for managing the seizure patient, including formulation of the treatment plan when cannabinoids are used
    • Employ strategies that integrate care across disciplines

CME INFORMATION

The University of Vermont College of Medicine is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing medical education for the healthcare team.

The University of Vermont designates this enduring material activity for a maximum of 7.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is made up of 5 individual modules that can be completed independently. This program has been reviewed and is approved for pharmacists for a maximum 7.75 hours/0.775 CEU ACPE  0621-0000-16-001-H01-P. To obtain a CE certificate for a CME module qualified pharmacists must complete the CME module in its entirety and an evaluation, and score 80% or higher on the post-assessment test for the module.